Regardless of improving menopausal symptoms and anthropometric parameters, the effects of the multidisciplinary team activities in early postmenopausal women may be similar to those in late postmenopausal women.

Despite the sleep data, melatonin may be involved in the precocious puberty process.

edMund cHada baracat 7 Artigos originaisResumo ObjetivO: analisar os efeitos da isoflavona e do estrogênio sobre a qualidade de vida de mulheres na pós-menopausa. MétOdOs: realizou-se estudo randomizado, duplo-cego, com 79 pacientes, amenorréia de 12 meses, idade superior a 40 anos e índice de massa corporal (IMC) superior a 30 kg/m 2 . As mulheres foram aleatoriamente divididas em dois grupos de tratamento: GECP recebeu duas cápsulas, via oral, de 12/12 horas, uma contendo 0,625 mg de estrogênios conjugados eqüinos e, a outra, placebo (n=33); GECS recebeu duas cápsulas de 150 mg de extrato de soja, com 60 mg de isoflavonas cada (n=32), por seis meses. O Questionário de Qualidade de Vida Específico para Menopausa foi empregado antes e após um, três e seis meses de tratamento. Os parâmetros do risco de câncer ginecológico foram avaliados. Para análise dos dados, aplicaram-se os testes de ANOVA e de Tukey. ResultadOs: quanto aos parâmetros vasomotores, houve redução nos valores após seis meses de tratamento, 1,6±0,8 e 2,4±1,6, em relação aos valores antes da terapia, 4,0±2,2 e 4,2±2,3, respectivamente, nos GECP e GECS. Os aspectos psicossociais mostraram diminuição dos valores após seis meses de terapia, 2,5±1,2 e 2,9±1,4, em relação aos valores antes da terapia, 3,6±1,6 e 4,1±1,9, respectivamente, nos GECP e GECS. De forma semelhante ocorre no aspecto físico e nos sintomas sexuais. COnClusÕes: as isoflavonas agem positivamente na qualidade de vida de mulheres na pós-menopausa, semelhantemente aos estrogênios conjugados eqüinos. AbstractPuRPOse: to analyze the isoflavone and estrogen effects on the postmenopausal quality of life. MethOds: this is a randomized and double-blind study with 79 postmenopausal patients, 12 months of amenorrhea, 40 years old or more and body mass index (BMI) above 30 kg/m 2 . The participants were randomly divided into two treatment groups: GECP received orally two capsules, every 12 hours, one contained 0.625 mg conjugated equine estrogen and another placebo (n=33); GECS received two capsules of 150 mg extract of soy, with 60 mg isoflavone (n=32). Both treatments were administered for six months. The Quality Menopause Specific Questionnaire of Life was applied before and after one, three and six months of treatment. The parameters of gynecological cancer risk were evaluated. ANOVA and the Tukey test were used for data analysis. Results: there was a reduction in the values of the vasomotor parameters after six months of treatment, 1.6±0.8 and 2.4±1.6, compared to before therapy, 4.0±2.2 and 4.2±2.3 in GECP and GECS, respectively. The psychological aspects showed reduction in values after six months of therapy, 2.5±1.2 and 2.9±1.4, compared to before treatment, 3.6±1.6 and 4.1±1.9 in GECP and GECS, respectively. Similar results were obtained on the physical aspects and in the sexual symptoms. COnClusiOns: isoflavones may positively act on life quality of postmenopausal women. This effect was similar to conjugated equine estrogen.

Objective: To evaluate the performance of a sample of postmenopausal women complaining of decline of prospective memory, undergoing therapy with concentrated extract of soy (CES) for six months, through specific neuropsychological assessment, developed for this purpose. Materials and Methods: A randomized and double-blind study was with 90 women, 12-month amenorrhea, 40 years to 65 years and body mass index (BMI) above 30 kg/m 2 , whose complaints were reduction of cognitive efficiency. The participants were randomly divided into two treatment groups: Group I-received one capsule of 150 mg extract of soy, with 60 mg isoflavones orally/day; Group II-received one capsule placebo, for six months. All participants underwent a detailed interview, the MMSE, depression scale, and as they were being included in the study, self-perception scales and neuropsychological tests before and after six months of treatment. For analysis purposes, we applied the ANOVA and t-student tests. Results: Our results suggest a possible positive effect regarding the improvement in verbal fluency and executive function tasks of planning and mental flexibility, in women undergoing therapy with concentrated extract of soy in postmenopause. There was no correlation between prospective memory and cognitive performance, and there were only intensity scores of the depressive symptoms. Conclusion: Isoflavones act favorably on the cognitive function, amongst all functions, only on verbal memory and executive function tasks of planning and mental flexibility. The others showed no signs of improvement. We concluded that concentrated extract acts only on some cognitive functions.